J&J Study Predicted 37% Failure Rate for Hip Implants

J&J Study Predicted 37% Failure Rate for Hip Implants

Emile Wamsteker/Bloomberg

J&J, based in New Brunswick, New Jersey, said in a November filing with the U.S. Securities and Exchange Commission that it increased reserves “due to anticipated product liability litigation and costs associated with” the ASR hips.